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Abstract
Background—Seasonal influenza vaccination is recommended for all asthma patients. Persons 
with work-related asthma may have more severe disease than those with non–work-related asthma 
and may particularly benefit from receiving influenza vaccination.
Purpose—To determine if influenza vaccination coverage differs among individuals aged 18–64 
years with work-related and non–work-related asthma.
Methods—Data from the 2006–2009 Behavioral Risk Factor Surveillance System Asthma Call-
Back Survey collected in 38 states and the District of Columbia were analyzed in 2013. 
Multivariable logistic regression and predictive marginal analyses were conducted to identify 
factors independently associated with influenza vaccination among respondents aged 18–64 years 
with work-related asthma.
Results—Among adults aged 18–64 years with current asthma, an estimated 42.7% received 
influenza vaccination in the past 12 months. Although influenza vaccination coverage was 
significantly higher among adults with work-related asthma than those with non–work-related 
asthma (48.5% vs 42.8%), this association became non-significant after adjustment for 
demographic and clinical characteristics (prevalence ratio=1.08, 95% CI=0.99, 1.20). Among 
individuals with work-related asthma, receiving the influenza vaccine was associated with being 
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50–64 years old, being unemployed in the prior year, and seeking urgent treatment for worsening 
asthma symptoms.
Conclusions—Among persons with work-related and non–work-related asthma, less than half 
received influenza vaccination in the prior year, both below the Healthy People 2010 target of 
60%. These results suggest the need for strengthening current vaccination interventions to meet 
the updated Healthy People 2020 objective of achieving at least 70% influenza vaccination 
coverage.
Introduction
In 2010, an estimated 18.7 (8.2%) million U.S. adults had asthma.1 Asthma was the most 
frequently reported comorbid condition among patients hospitalized with 2009 H1N1 
influenza.2 Annual influenza vaccination is the most effective method for preventing 
infection with influenza virus, preventing infection-associated complications, and reducing 
work absenteeism.3–6 In 2006–2009, annual influenza vaccination was recommended for 
adults with asthma.4,7–11
Work-related asthma (WRA) is asthma that is caused or exacerbated by work-related 
factors.12 We previously reported that among adults with current asthma, 9% were 
diagnosed with WRA and an additional 38% describe their asthma as caused or worsened by 
workplace exposures (possible WRA).13 Persons with WRA have lower SES and may have 
more severe disease than those with non-WRA.13–15 Therefore, persons with WRA may be 
at higher risk for severe asthma exacerbation associated with influenza virus infection than 
those with non-WRA.16,17
Although previous studies have examined influenza vaccination coverage in persons with 
asthma, no information is available for those with WRA. 18–20 Data from the 2006–2009 
Behavioral Risk Factor Surveillance System (BRFSS) Asthma Call-Back Survey (ACBS) 
were analyzed to determine influenza vaccination coverage differences among individuals 
with WRA and non-WRA.
Methods
A detailed description of the survey methods is available else-where.21–23 Classification of 
asthma, asthma-related healthcare utilization, asthma outcomes, and asthma control were 
based on previously used definitions.13–15 Participants with current asthma were classified 
as having WRA (diagnosed), possible WRA, and non-WRA (referent group). Influenza 
vaccine recipients were those who received an influenza vaccine injection or nasal spray. 
Number of physician contacts for asthma in the past 12 months was calculated based on 
information on the number of doctor's visits for routine asthma checkup, urgent treatment of 
worsening asthma symptoms, or an asthma episode or attack, as well as the number of 
asthma-related emergency room visits.
Statistical Analysis
Analyses were performed in 2013 following previously used methods using SAS, version 
9.3 (SAS Institute Inc., Cary NC) and SUDAAN, Release 10.0.1 (Research Triangle 
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Institute, Research Triangle Park NC).15,23 We restricted analyses to adults aged 18–64 
years with current asthma because of the age- and condition-specific recommendations for 
influenza vaccinations during 2006–2009.4,7–10
Results
A total of 55,105 adults aged ≥18 years ever diagnosed with asthma participated in ACBS in 
2006–2009; of these a total of 28,809 (representing an estimated annual average of 14.4 
million) adults with current asthma aged 18–64 years were included in this analysis. The 
median response rates among the 38 states and District of Columbia providing data for this 
report ranged from 47.5% to 51.4% for BRFSS and 47.2% to 54.3% for ACBS.21,22
Of all adults aged 18–64 years with current asthma, an estimated annual average 42.7% 
received influenza vaccination during 2006–2009 (range: 25.8% for persons with no health 
insurance to 60.3% for those who stayed overnight in a hospital) (Table 1). Although 
coverage was higher among adults with WRA than those with non-WRA (48.5% vs 42.8%, 
respectively), the association between WRA status and vaccination coverage was not 
significant after adjusting for covariates (adjusted prevalence ratio=1.08; 95% CI=0.98, 
1.20).
Influenza vaccination coverage and multivariate logistic regression results for influenza 
vaccination by WRA status are shown in Table 2. Influenza vaccination coverage among 
persons with non-WRA (an estimated 7.7 million) ranged from 26.1% among persons with 
no health insurance to 61.2% among those who stayed overnight in a hospital because of 
asthma in the past 12 months.
On multivariate analysis, among persons with non-WRA, vaccination coverage was 
significantly higher in subgroups similar to those for all adults with current asthma. 
Influenza vaccination coverage among persons with WRA (an estimated 1.3 million) ranged 
from 36.6% among non-Hispanic blacks to 58.6% among Hispanics and was significantly 
associated with age 50–64 years, lack of employment, and receiving urgent treatment for 
worsening asthma. Overall, vaccination coverage was significantly higher among asthmatics 
with a history of at least one physician contact in the previous year compared with those 
with no contact (Table 2).
Discussion
In this population-based study, the estimated annual average influenza vaccination coverage 
during 2006–2009 in adults aged 18–64 years was 48.5% in those with WRA and 42.8% in 
those with non-WRA. These rates were higher than those of the general age-matched U.S. 
adult population during the 2006–2007 season (39.9%) but less than the Healthy People 
2010 target of 60%.19,24 These results are similar to other studies showing that vaccine 
uptake in adults is suboptimal.19,20,25–27 The notable vaccination coverage difference among 
adults with WRA was the increased likelihood of vaccination among the unemployed. This 
may reflect the association between severity of WRA and job loss.28,29
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Barriers to vaccination include lack of knowledge about these vaccines among adult patients 
and healthcare providers, the perception of feeling healthy, vaccine safety concerns, 
vaccination costs, lack of health insurance, and lack of financing mechanisms.25,30 Low 
influenza vaccination coverage among employed adults and those with routine asthma 
checkups may indicate missed opportunities for vaccination.
Also, contrary to previous reports,27,31 among all asthma patients with at least one physician 
visit, influenza vaccination coverage did not increase with increasing number of physician 
contacts.9 No data were available in the ACBS to examine potential factors (e.g., vaccine 
availability, vaccination policies, public and clinician knowledge and practices, person's 
belief that they were in a high-risk group) that would explain why vaccination opportunities 
have been missed.8,30,32 The use of electronic health records with clinical decision support 
and physician prompts may improve influenza vaccination rates.33
Additionally, influenza vaccination coverage may be increased by offering and improving 
vaccination in workplaces.34 Blank et al.30 reported that the most important motivating 
factors for receiving influenza vaccine in the U.S. were media advertising, physician's 
advice, and advice from family, friends, or relatives. The authors concluded that 
improvement in vaccine coverage rates can be achieved by accurate communication of 
health information, particularly by physicians. Similar results have been reported by 
others.32,35,36
Across all analyzed groups, the lowest influenza vaccination coverage was noted among 
persons without health insurance. In the coming years, access to medical care and preventive 
services, including influenza vaccination, is expected to improve owing to passage of the 
Patient Protection and Affordable Care Act of 2010.27,37
Information on asthma and influenza vaccination was not validated; thus, estimates may be 
subject to misclassification. However, previous studies have found self-report of adult 
influenza vaccination to be reliable compared with reviews of medical records.38,39 This 
analysis used combined data years and influenza vaccination reported in the past 12 months 
rather than influenza season– specific coverage, which may produce different vaccination 
prevalence (http://cdc.gov/flu/fluvaxview/index.htm).
The cross-sectional design of BRFSS does not allow for examination of causal associations 
between adverse asthma outcomes and receiving influenza vaccination. For example, it is 
not clear whether influenza vaccination occurred before, during, or after unscheduled asthma 
treatment. Also, during 2006–2009, persons who resided in households that lacked a 
landline telephone and those who only used cellular telephones were not interviewed, likely 
resulting in vaccination coverage overestimatation.40 Finally, estimates are limited to the 38 
states and District of Columbia and do not represent the entire U.S. population.
Conclusions
More effective influenza vaccination and communication strategies are needed to meet the 
updated Healthy People 2020 goal of increasing annual influenza vaccination coverage 
among adults aged ≥18 years to 70%.41
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Table 1
Characteristics of adults aged 18–64 years with current asthma and influenza vaccination 
coveragea
Characteristics n in sampleb Population %c (95% CI)
Influenza vaccination coverage
%d (95% CI) PRe (95% CI)
Age group (years)
 18–49 13,956 70.1 (69.0, 71.1) 36.3 (34.5, 38.2) 1.00 (ref)
 50–64 14,853 29.9 (28.9, 31.0) 57.5 (55.9, 59.1) 1.52 (1.43, 1.61)
Gender
 Male 7,525 37.9 (36.4, 39.4) 38.9 (36.3, 41.5) 1.00 ref
 Female 21,284 62.1 (60.6, 63.6) 45.0 (43.5, 46.5) 1.13 (1.05, 1.21)
Race/ethnicity
 White, non-Hispanic 23,191 74.1 (72.8, 75.5) 44.4 (42.9, 46.0) 1.00 ref
 Black, non-Hispanic 1,721 9.0 (8.2, 9.8) 34.5 (30.3, 38.7) 0.81 (0.71, 0.92)
 Hispanic 1,446 9.6 (8.6, 10.6) 37.0 (31.6, 42.4) 0.94 (0.82, 1.09)
 Other, non-Hispanic 2,271 7.3 (6.5, 8.1) 42.1 (36.5, 47.8) 1.01 (0.89, 1.15)
Education level
 ≤High school 9,462 34.3 (32.9, 35.8) 39.7 (37.0, 42.4) 0.98 (0.91, 1.06)
 >High school 19,331 65.7 (64.2, 67.5) 44.3 (42.7, 45.9) 1.00 ref
Household income ($)
 <50,000 14,911 51.0 (49.5, 52.4) 38.4 (36.4, 40.4) 1.00 ref
 ≥50,000 11,564 49.0 (47.6, 50.5) 47.0 (45.0, 48.9) 1.13 (1.06, 1.21)
Health insurance
 Yes 25,327 85.9 (84.8, 87.1) 45.5 (44.0, 46.9) 1.00 ref
 No 3,383 14.1 (12.9, 15.2) 25.8 (21.6, 30.0) 0.64 (0.54, 0.75)
Employment statusf
 Employed 17,538 64.0 (62.6, 65.4) 41.3 (39.6, 43.0) 1.00 ref
 Not employed 11,271 36.0 (34.6, 37.4) 45.3 (42.9, 47.7) 1.04 (0.96, 1.12)
Work-related asthma
 Work-related asthma 3,003 8.9 (8.3, 9.6) 48.5 (44.7, 52.4) 1.08 (0.98, 1.20)
 Possible work-related asthma 11,421 36.9 (35.5, 38.2) 41.1 (39.0, 43.3) 0.98 (0.92, 1.05)
 Non–work-related asthma 14,226 54.2 (52.8, 55.6) 42.8 (40.8, 44.8) 1.00 ref
Other chronic diseaseg
 Yes 6,170 15.3 (14.5, 16.1) 53.4 (50.7, 56.1) 1.16 (1.08, 1.24)
 No 22,372 84.7 (83.9, 85.5) 40.8 (39.2, 42.3) 1.00 ref
Ability to see a doctor for asthma if neededf
 Yes 25,442 87.7 (86.7, 88.6) 44.6 (43.1, 46.0) 1.27 (1.12, 1.46)
 No 3,213 12.3 (11.4, 13.3) 29.8 (26.3, 33.3) 1.00 ref
Routine checkup for asthmaf
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Characteristics n in sampleb Population %c (95% CI)
Influenza vaccination coverage
%d (95% CI) PRe (95% CI)
 Yes 24,559 86.5 (85.5, 87.5) 42.9 (41.4, 44.4) 1.02 (0.92, 1.13)
 No 3,965 13.5 (12.5, 14.5) 41.1 (37.4, 44.8) 1.00 ref
Physician contactsh
 None 11,567 42.5 (41.1, 43.9) 32.1 (30.2, 34.0) 1.00 ref
 1 5,127 18.7 (17.5, 19.9) 49.8 (46.1, 53.5) 1.40 (1.27, 1.54)
 2–3 5,434 18.7 (17.7, 19.7) 48.6 (45.7, 51.5) 1.40 (1.28, 1.52)
 4–9 4,683 14.0 (13.1, 14.8) 52.4 (49.1, 55.7) 1.42 (1.30, 1.55)
 ≥10 1,898 6.1 (5.5, 6.7) 50.7 (45.7, 55.6) 1.48 (1.30, 1.69)
Asthma control
 Well controlled 13,817 50.6 (49.2, 52.1) 40.3 (38.4, 42.3) 1.00 ref
 Not well controlled 7,438 27.1 (25.8, 28.4) 43.1 (40.3, 45.9) 1.10 (1.02, 1.19)
 Very poorly controlled 7,543 22.2 (21.2, 23.3) 47.7 (45.1, 50.3) 1.16 (1.07, 1.25)
Adverse asthma outcomesf
 Asthma attack
  Yes 15,653 53.0 (51.6, 54.5) 44.4 (42.5, 46.3) 1.08 (1.01, 1.15)
  No 12,902 47.0 (45.5, 48.4) 40.7 (38.6, 42.8) 1.00 ref
 Urgent treatment for worsening asthma
  Yes 7,251 23.4 (22.4, 24.5) 49.2 (46.6, 51.7) 1.18 (1.10, 1.26)
  No 21,155 76.6 (75.5, 77.6) 40.3 (38.7, 41.9) 1.00 ref
 Asthma-related emergency room visit
  Yes 3,578 12.2 (11.3, 13.1) 45.0 (41.1, 48.9) 1.08 (0.97, 1.20)
  No 25,083 87.8 (86.9, 88.7) 42.1 (40.7, 43.6) 1.00 ref
 Overnight stay in hospital because of asthma
  Yes 1,120 3.2 (2.7, 3.7) 60.3 (53.5, 67.0) 1.28 (1.11, 1.45)
  No 27,531 96.8 (96.3, 97.3) 41.9 (40.5, 43.3) 1.00 ref
Total 28,809 42.7 (41.3, 44.1)
Note: Boldface indicates significance.
a
Data were collected in 38 states (Alaska, Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, 
Louisiana, Maine, Maryland, Massachusetts, Michigan, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New 
York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and 
Wisconsin) and the District of Columbia during 2006–2009.
b
Unweighted sample size (the numbers may not add up to the total because of missing values)
c
Distribution presented as weighted average annual estimate
d
Proportion presented as weighted average annual estimate
e
Adjusted for age, gender, race/ethnicity, annual household income, health insurance, and chronic disease. For each model, the outcome variable 
was influenza vaccination.
f
In the past 12 months
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g
Diabetes or cardiovascular disease
h
Includes doctor's visits for routine asthma checkup, doctor's visits for urgent treatment of worsening asthma symptoms or an asthma episode or 
attack, and emergency room visits because of asthma in the past 12 months
PR, prevalence ratio
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